"Mid Hudson Medical (MHM) Research is a multi-specialty investigative center in upstate New York. MHM Research was founded in 2007 by Sashi Makam, MD, an Internist with over 15 years experience. Mid Hudson Medical Research's mission is to provide unparalleled patient care coupled while collecting excellent study data"

During the past decade, Mid-Hudson Medical Research, PLLC - New Windsor conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mid-Hudson Medical Research, PLLC - New Windsor" are "Severe Hypertriglyceridemia" (2 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Mid-Hudson Medical Research, PLLC - New Windsor" in a lesser frequency.

Most popular intervention types in "Mid-Hudson Medical Research, PLLC - New Windsor" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo (for K-877)" (2 trials), "Obicetrapib" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mid-Hudson Medical Research, PLLC - New Windsor" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Mid-Hudson Medical Research, PLLC - New Windsor". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mid-Hudson Medical Research, PLLC - New Windsor, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mid-Hudson Medical Research, PLLC - New Windsor, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".